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Real-world effectiveness of influenza vaccination 





Ageing is associated with a decline in the normal function of the immune system which may 
limit the effectiveness of the influenza vaccine. However, the absence of strong evidence 
from randomised controlled trials and conflicting results from observational studies has led 




To determine the real world effectiveness of the influenza vaccine in UK adults aged 65y and 






Quasi-experimental cohort study of patients in the UK from general practices registered to 
the Clinical Practice Research Datalink with linkage to Hospital Episode Statistics and the 




Adults aged 65y and over, recruited, starting in September, in annual cohorts from 1997 to 








Hospitalisation for influenza, and prescriptions for antibiotics for symptoms consistent with 




Application of the pairwise Prior Event Rate Ratio (PERR) method to estimate vaccine 
effectiveness in each annual cohort after removing the effect of time-invariant unmeasured 
confounding using outcomes from the year before vaccination. Vaccination effectiveness 
was also studied by age and pneumococcal (PPV) vaccination subgroups. 
 
Results 
The rates of influenza in the year before vaccination were higher for patients that 
proceeded to be vaccinated than for patients who remained unvaccinated, indicating the 
presence of confounding bias. Adjustment for this bias using the pairwise PERR method, 
showed that influenza vaccination was moderately effective in all cohorts (HR ranging from 
0.59 in 2012 to 0.89 in 2001, all significant at the 5% level except 2001). There was no 
discernible difference in influenza effectiveness between the PPV subgroups, although 
accuracy was affected by fewer patients in the PPV group. There was also no significant age 





The UK policy of vaccinating older adults is effective at reducing risk of influenza infection. 
There was no clear evidence to suggest influenza vaccine effectiveness was attenuated by 
the pneumococcal vaccine and no consistent moderation of effectiveness with increasing 
age. 
 
 
